CASE REPORT
Accepted on 14 Aug 2025
PEComa Progressed by mTOR Inhibitor Therapy with Anti-VEGFR TKI Combined with PD-1 Inhibitor：a case report
doi 10.3389/fonc.2025.1628650
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Beyond Conventional Biomarkers: Unlocking Immunotherapy Response Through Novel Biomarkers or Combinatorial Approaches
Beyond Conventional Biomarkers: Unlocking Immunotherapy Response Through Novel Biomarkers or Combinatorial Approaches
971
Total downloads
6,215
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 25 Jul 2025
Blood memory CD8 T cell phenotypes in lung cancer patients predict immune checkpoint treatment responses
doi 10.3389/fonc.2025.1629802
- 196 views
ORIGINAL RESEARCH
Published on 05 May 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer
doi 10.3389/fonc.2025.1579214
- 2,130 views
ORIGINAL RESEARCH
Published on 16 Apr 2025
The Lung Cancer Immune Prognostic Score predicts pathologic complete response and survival in NSCLC patients receiving neoadjuvant immunochemotherapy
doi 10.3389/fimmu.2025.1567565
- 2,011 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: